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In animalexperiments,high doses of catecholamines
exhibit cardiotoxicity and can produce myocardial
hecroses (see review of literature by HECHT [4])
which are mediated by an excessive Ca++ influx
into the myocardium. In contrast, the effect on
the fetal heart following treatment of pregnant
animals with catecholamines is largely unknown.
In the investigations described here the following
questions were to be answered:
1. Do high doses of the sympathomimetic fenoterol
given to pregnant rats cause alterations in the
weight and histologjcal appearances of the
hearts of fetuses and young animals similar to
those described in adult animals by MARMO et
al. [6]?
2. Does treatment with fenoterol and isoprenaline
produce a rise in myocardial calcium influx in
fetuses similar to that reported in mother animals
by FLECKENSTEIN [2] and ARNDTS [1]?
S.What are the differences in concentration of
fenoterol between fetal and maternal myo-
cardium?
l Materials and Methods
All investigations were carried out on rats of the
Chbb: THOM (SPF) strain. Animals were main-
tained under standardised conditions (aircondi-
tioned, germ free rooms; environmental temperature
22°C ± 1°, relative humidity 55% ± 3;lightdark
rythm 12 : 12 hours; Altromin - R® standardised
dry feed peUets from Firma ALTROMIN GmbH,
Lage/Lippe, and drinking water ad libitum).
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For the anatomical and histological investigation,
20 pregnant rats were given fenoterol1) = l - (3,5-
dihydroxy-phenyl)-2 ((l ,4-hydroxy-benzyl)-ethyl)-
amino)-ethanol-hydrobromide from the 18th to
the 22 st day of pregnancy (day of presence of
sperms in vaginal smear = Ist day of pregnancy).
A further 10 pregnant animals served äs controls.
Subcutaneous dosages were 5.5 and 11 mg/kg
body weight/day. The substance was dissolved in
0.9% NaCl; the volume used was 0:5 ml/100 g
body weight. Half of the animals were delivered by
caesarean section, the other half delivered spontan-
eously and reared their young for three weeks.
*) PARTUSISTEN®, Manufacturer: C. H. BOEHRINGER
SOHN, INGELHEIM.
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After killing, the hearts of mothers, fetuses and
young were removed and the ventricular weights
determined. Absolute heart weights were analysed
statistically using the t-Test, the relative weights
by the U-test according to WILCOXON et al. [10].
The hearts were fixed in 5% neutral buffered
formalin and embedded in Paraplast. Sections
were stained with H. E., Masson's trichrome stain
and Perl's method for iron. Frozen sections were
stained with Fettrot 7B. All H. E. sections were
examined additionally under polarised light
according to the method of PILNY et al. [7]. The
histological changes were graded arbitrarily
according to the severity and extent of the lesions
äs follows:
1. Mild changes: recognised äs focal areas of inter-
stitial oedema with increased eosinophilia of
individual myocytes, small collectionsofmono-
cytes and histiocytes in the interstitium with
slight haemosiderin deposition and slight
Collagen formation. These changes were con-
fined to the subendocardial region of the left
ventricle commencing at the apex.
2. Moderate changes: consisted of more marked
degenerative changes in myocytes and more
intense cellular Infiltration with moderate
haemosiderin deposition and collagen formation.
These changes extended more deeply and more
cephally in the wall of the left ventricle and
interventricular septum, remaining focal in
most instances.
Three groups each of five animals in the 21 st day
of pregnancy were used for the estimation of
myocardial calcium influx. Group l (controls)
received 0.2 rnl physiological saline, group 2,
20 mg/kg body weight isoprenaline and group 3,
11 mg/kg body weight fenoterol subcutaneously.
Simultaneously 10 jug/kg 45CaCl2 (= 100 //Ci/kg)
dissolved in 0.5 ml saline was administered äs a
tracer. After 6 hours exposure, the rats were
anaesthetized with ether and subjected to thora-
cotomy, äs described previously by ARNDTS [1].
5 ml blood were taken from the right atrium,
heparinised and centrifuged. Then the heart was
removed and the right ventricle was dissected and
weighed. The fetuses were removed and decapitated.
The blood of all individuals from each litter was
pooled (0.5-1.0 ml), heparinised and centrifuged.
The fetal hearts were dissected and weighed. The
preparation of the tissue and plasma samples was
published previously by ARNDTS [1]. The 45Ca-
content in the heart tissue was given äs a percentage
relative to the particular plasma activity (% A).
Thus, for each animal, the absolute value of the
ventricular sample was calculated äs a percentage




X 100 = % Amaternal
X 100 = % Afetal
cpm/fetal plasma
The radioactivity in the fetal plasma was the average
value of the pooled blood plasma from all animals
in each litter.
Twenty pregnant animals were used for the
estimation of fenoterol and its metabolites in the
myocardium of dams and fetuses. The animals
were divided into 4 groups each of 5 animals.
Paired groups received daily 5.5 and 11 mg/kg
fenoterol respectively subcutaneously from the
18th to the 22nd day of pregnancy. In one group
of each pair only the last dose of fenoterol
(22nd day) was radioactively labelled, the other
group receiving five doses of radioactive sub-
stance (tritium labelling in position 1). We injected
0.1 ml/100 mg body weight. Solutions contained
5.5 or 11 mg 3H-fenoterol/ml saline (^ 211.5 or
197.7 / ).
On the 22nd day of pregnancy the animals were
anaesthetised with ether l hour after the last dose.
After thoracotomy, the dams were bled by heart
puncture and the hearts were then removed. The
fresh weights of the hearts of all dams and fetuses
were determined. The tissue levels of substance
and metabolites combined were estimated from
the radioactive content; the tissue level of the
substance itself was determined by selective ion-
pair extraction. The estimation of the radioactivity
was carried out according to ROMINGER and
POLLMANN [9]. The radioactivity levels determined
were converted to quantities of substance using
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the specific radioactivity of the applied solution
and expressed s concentration levels with respect
to the fresh weight.
2 Results
From the 30 pregnant animals, 367 offspring were
obtained. 190 fetuses were obtained by caesarean
section (69 from control dams and 121 from treated
animals) while 173 live births and 4 stillbirths (66
live births from control dams and 107 live births
and 4 stillbom from treated dams) followed normal
delivery. Four young (l from a control dam and 3
from treated dams) died during the three week
post natal period. Canabalism was the immediate
cause of death in most cases.
After subcutaneous administration of 5.5 and
, 11 mg/kg body weight fenoterol, slight but
statistically significant increases in the mean heart
weights of treated dams were found (Tab. I). No
differences in heart weights were seen in the fetuses
and young in comparison to the controls. The
histopathological fmdingsare summarised in Tab. II.
All control females showed normal histological
appearances. Of the 20 females given fenoterol
subcutaneously, 10 showed moderate changes, the
remainder exhibiting only mild alterations. Infarct-
like areas of myocardial necrosis were not seen in
any of the animals.
In contrast, all of the 359 fetuses and newborn
examined (133 control: 226 treated), including 3
stillbirths and l neonatal death, showed normal
histological appearances.
Tab. III summarizes the treatment and the 45Ca-
uptake in maternal and fetal hearts (% A) following
s.c. injections of isoprenaline, fenoterol or saline
to pregnant rats. A total of 204 fetal hearts were
measured. No effect on 45Ca-uptake in any fetal
ventricle, independent of the drug administered,
is seen.
The reliability of our technique is demonstrated
in column (e) of Tab. III. We confirmed those
effects of isoprenaline on the myocardial 45Ca-
uptake previously published by FLECKENSTEIN
[3]. These results demonstrate a higher cardio-
toxicity of isoprenaline than of fenoterol. Adult
male rats are more sensitive than female, non
pregnant females more than pregnant.
The fenoterol and metabolite concentrations
determined in the maternal and fetal heart are
summarised in Tab. IV. The concentrations of
metabolitesof fenoterol (two isomeric ghicuronides,
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711.1 0.322 5.21 25.6 0.491
79.1
1027.5 0.460* 5.25 30.3 0.577
257.6
973.5** 0.421 4.92 ' 28.3 0.576
108.1
768.5 0.345 38.43 153 0.398
54.2
870.8* 0.380 44.28 171 0.386
52.3
879.5* 0.393 41.43 170 0.410
' 65.5
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Tab. III. Myocardial 45Ca-uptake in maternal and fetal right ventricles following subcutaneous isoprenaline, fenoterol or



































45Ca-uptake in 45Ca-uptake in
maternal ventricles fetal ventricles |d]
[c]
(N) fetuses mean





























































































34 ± 6.1 32 ± 2.7
215 ± 53.2 120 ± 13.6
108 ±35.6 61 ± 8.7
* ± S.D. (Standard deviation)
POOK et al. [8]) in fetal hearts lie at one tenth of
the maternal values. In contrast, the fenoterol
concentrations in the hearts of fetuses are l/200th
to l/500th of the values found in maternal hearts.
While the concentrations of fenoterol in maternal
and fetal hearts did not differ after single or
multiple 3H-fenoterol administration, the concen-
J. Perinat. Med. 5 (1977)
trations of fenoterol metabolites after multiple
administration were clearly raised.
3 Discussion
The questions we raised regarding the effects on
the hearts of the fetuses and young of pregnant
15*
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Tab. IV. Concentration of fenoterol and fenoterol met-
abolites in matemal and fetal heart tissue of rats*.














































* Mean ± Standard deviation, n = 5
rats given high doses of fenoterol can be answered
äs follows:
l. Fenoterol, given subcutaneouslyup to amaximum
of 10.000 times the human therapeutic dose,
has no effect on the absolute or relative ventric-
ular weights of fetuses or young. A slight, but
nonetheless statistically significant increase in
heart weightwasfound in dams. The histological
fmdings are largely in agreement with these
results. No histological evidence of myocardial
damage was found either in newborn or 3 week
old animals.
Although the high sub cutaneous doses of fenoterol
produced mild to moderate changes in maternal
hearts, infarct-like areas of myocardial necrosis
typical of catecholamine toxicity were not seen.
Indeed MARMO et al. [6] were unable to produce
such necrosis in adult rats given 100 mg/kg body
weight of fenoterol, intramuscularly, daily for
4 days. The cardiotoxfc effect of sympatho-
mimetics ismediatedby an excessive Ca"1"* influx
into the myocardium, activating contractility
and exhausing the ATP Stores.
2. No increase in myocardial calcium influx was
seeninfetusesfrom dams treated with fenoterol.
Isoprenaline also did not cause a rise in fetal
myocardial influx. Thus, the in vitro catechol-
amine sensitivity demonstrated by KAUFMANN
et al. [5], using isolated embryonal chicken
hearts, can not be shown to produce cardiotoxic
effects on the fetal heart in vivo.
S.Marked differences have been shown between
the tissue concentrations of fenoterol and its
metabolites in maternal and fetal hearts. Very
low concentrations were found in the fetuses.
As shown by the estimation of the concentrations
of fenoterol and its metabolites in dams and
fetuses, the placental transfer of fenoterol to
the fetus is markedly reduced. No accumulation
of fenoterol in the fetal heart is demonstrated
after daily subcutaneous injection of the mother
for 5 days. The transfer of fenoterol metabolites
is also markedly impaired, although not to the
same extent äs the substance itself. The mechanism
responsible for the impairment of the placental
transfer has not been determined.
The exceptionally low concentrations of fenoterol
in the fetal hearts explain why the dosages used,
although affecting the dams, were not cardiotoxic
in the fetuses.
Summary
It was intended to determine, whether high doses of
the sympathomimetic tokolytic drug fenoterol
(PARTUSISTEN®) cause cardiotoxic effects in fetuses
following administration to pregnant rats. We investigated
in fetuses the following details:
1. Is there any myocardial necrosis or an increase of
cardiac wheight?
2. Is the fetal myocardial 45Ca-uptake increased to the
same degree äs in adult rats?
3. Is there any diaplacental transfer of fenoterol?
1. For morphological study, 20 pregnant rats were given
either 5.5 or 11 mg/kg/day of fenoterol subcutaneously
from the 18th to the 22nd day of pregnancy. From 10
rats the fetuses were taken by caesarean section and
sacrificed immediätely. Theremaining rats were allowed
to deliver normally and rear their young for 21 days.
The absolute and relative heart weights of dams., fetuses
and young were determined and statistically analysed.
Routine and specially stained sections were examined
by direct and polarised light microscopy.
2. The myocardial ^Cä^-influx was determined at the
21 st day of pregnancy. 5 pregnant rats receiyed V.c.
saline, 30 mg/kg isoprenaline or 11 mg/kg fenoterol.
To all animals 10 Mg/kg 45CaCl2 (dissolved in l ml saline)
was given Lp. After 6 hours radioactivity was determ-
ined in the right ventricle and in the blood plasma from
dams and fetuses. The absolute radioactivity of the
ventricle was calculated äs a percentage relative to the
plasma value.
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3. Fenoterol and its metabolites were determined in the
myocardium from 2 groups of rats and fetuses follo wing
s.c. injections of 5.5 or 11 mg/kg fenoterol from the
18th to the 22nd day of pregnancy. To 5 animals from
each group radioactively labeled fenoterol was ad-
ministered every day, the remaining 5 rats of either
gioup received only one single radioactive injection at
the 22 nd day. One hour after the last injection the
concentrations of both fenoterol and its metabolites
were determined in the myocardial tissue.
l.The heart weights of fetuses and young from rats
pretreated with fenoterol were exactly the same äs
from control animals (Tab. I) though the weights of
maternal hearts were slightly but significantly increased.
None of the fetuses or young examined showed
histological evidence of myocardial damage (Tab. II).
The treated dams showed mild to moderate myocardial
changes. Infarct-like areas of myocardial necrosis were
not observed in any of the animals.
2. Neither fenoterol nor isoprenaline caused increased
45Ca-uptake in the fetal ventricles. The increase in
myocardial calcium influx in fenoterol treated dams
was considerably less than in those treated with
isoprenaline (Tab. III). The tabulated results
demonstrate further that adult male rats are more
sensitive to catecholamine induced cardiotoxicity
thanfemales, non-pregnant animals more than pregnant.
3. The diaplacental passage of fenoterol is strongly inhi-
bited. The concentration of metabolites in fetal hearts
was approximately one tenth of that found in the
dams; the analogue quotient for fenoterol itself is l : 100.
There is no accumulation of fenoterol in the fetal
myocardium even after multiple administration.
The absence of changes in the fetuses and young are to be
explained by the very low placental transfer of fenoterol.
It is quiet unknown by which mechanism the diaplacental
transfer is inhibited.
Keywords: Calcium influx, diaplacental transfer, fenoterol, fetus, heart weight, myocardial necrosis, rat, tissue concen-
tration.
Zusammenfassung
Experimentelle Untersuchungen zur Frage kardiotoxischer
Effekte bei Nachkommen von Ratten, die mit hohen
Dosen Fenoterol behandelt wurden.
Es sollte geklärt werden, ob hohe Dosen des sympatho-
mimetischen Tokolytikums Fenoterol (PARTUSISTEN®)
bei Feten subkutan behandelter Muttertiere kardiotoxisch
wirkten. Folgende Detailfragen wurden untersucht:
Kommt es nach hohen Dosen beim Feten zu
1. Zunahme des Herzgewichts oder zu Myokardnekrosen,
2. vermehrter myokardialer Radiokalziumaufnahme wie
bei den Muttertieren
3. diaplazentarer Passage des Fenoterols?
1. Für die anatomischen und histologischen Untersuchun-
gen wurde an 20 trächtige Ratten 5,5 bzw. 11 mg/kg
Körpergewicht Fenoterol subkutan vom 18. bis 22.
Trächtigkeitstag verabreicht. Von 10 Muttertieren
wurden die Feten durch Kaiserschnitt entnommen und
sofort getötet; die andere Hälfte warf ihre Jungen
spontan und zog sie bis zum 21. Lebenstag auf. Es
wurden die absoluten und relativen Herzgewichte von
Muttertieren, Feten und Jungtieren bestimmt und
statistisch geprüft. Die z. T. mit Spezialfärbung prä-
parierten histologischen Schnitte wurden direkt und im
polarisierten Licht mikroskopisch untersucht.
2. Der myokardiale Kalziuminflux wurde am 21. Trächtig-
keitstag an 15 Tieren untersucht. Je 5 Muttertiere er-
hielten 0,85 %igeNaCl-Lösungbzw. 30 mg/kg Isoprenalin
oder 11 mg/kg Fenoterol subkutan. Als Tracer inji-
zierten wir i.p. allen Ratten 10 Mg/kg 45CaCl2 (gelöst in
l ml 0,85 % NaCl). Nach 6 Stunden wurde'die Radioak-
tivität im rechten Ventrikel und im Blutplasma von
Feten und Muttertieren bestimmt. Die Radioaktivi-
tätskonzentration im Ventrikel wurde auf diejenige
im Plasma bezogen und in Prozenten angegeben.
3. Fenoterol und seine Metaboiiten wurden im Myokard
von Muttertieren und Feten an 2 Gruppen zu je 10
Tieren bestimmt, die vom 18.-22. Trächtigkeitstag 5,5
bzw. 11 mg/kg Fenoterol subkutan injiziert bekamen.
Jeweils 5 Tiere aus jeder Gruppe erhielten an allen
Applikationstagen radioaktiv-markiertes Fenoterol
appliziert, die restlichen 5 Tiere je Gruppe nur eine
radioaktiv markierte Dosis am 22. Tag. Eine Stunde
nach der letzten Substanzgabe wurden die Gewebe-
spiegel von Fenoterol und Metaboiiten im maternalen
und fetalen Myokard bestimmt.
1. Die fetalen Herzgewichte Fenoterol-behandelter Mutter-
tiere unterschieden sich nicht von den Kontrollen
(Tab. I). Geringgradjge, jedoch statistisch signifikante
Zunahmen der Herzgewichte wurde bei den behandel-
ten Muttertieren festgestellt. Weder Feten noch Jung-
tiere wiesen histologisch Myokardschäden auf (Tab. II).
Die Fenoterol-behandelten Muttertiere zeigten geringe
bis mittelgradige Myokardveränderungen; infarktähn-
liche Bezirke wurden nicht festgestellt.
2. Weder Fenoterol noch Isoprenalin verursachten eine Zu-
nahme der 45Kalziumaufnahme in fetalen Ventrikeln.
DieZunahmedesmyokardialenKalziuminfluxFenoterol-
behandelter Muttertiere war beträchtlich geringer als
die nach Isoprenalinbehandlung (Tab. III). Die tabel-
larisch erfaßten Werte zeigen weiter an, daß erwachsene
männliche Ratten empfindlicher kardiotoxisch nach
Katecholaminbehandlung reagieren als weibliche; nicht-
trächtige wiederum stärker als trächtige.
3. Die diaplazentare Passage von Fenoterol und seinen
Metaboiiten ist stark gehemmt. Während die Metabolit-
konzentration im fetalen Myokardum eine Zehnerpotenz
niedriger ist als im maternalen Myokard, beträgt der
Konzentrationsunterschied beim Wirkstoff Fenoterol
vom maternalen zum fetalen Myokard mehr als 2 Zeh-
nerpotenzen. Eine Kumulation von Fenoterol im
fetalen Myokard nach mehrfacher Applikation konnte
nicht beobachtet werden.
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werden. Welche Mechanismen diese Hemmung der dia-
plazentaren Passage bewirken, ist nicht geklärt.
Die fehlenden Veränderungen des Myokardgewebes bei
Feten und Jungtieren können mit der äußerst geringen
diaplazentaren Passage des Wirkstoffs Fenoterol erklärt · t
Schlüsselwörter: Fenoterol, Feten, Gewebekonzentration, Herzgewicht, Kalziuminflux, Myokardnekrose, Plazenta-
passage, Ratten.
Resume
Examens experimentaux quant a Feventualite d'effets
cardiotoxiques chez la descendance de rates traitees a
hautes doses avec du Fenoterol.
II s'agissait desavoir si le sympathicomimetique-tocoly tique
Fenoterol (PARTUSISTEN@) applique a hautes doses par
voie sous-cutanee chez des rates gravides a une action
cardiotoxique sur les foetus. Les questions suivantes
furent examinees: Apres de hautes doses, observe-t-on
chez les foetus
1. augmentation du poids du coeur ou necroses du
myocarde,
2. absorption augmentee du radiocalcium dans le myo-
carde, comme chez les meres
3. passage diaplacentaire du Fenoterol?
1. En vue des examens anatomiques et histologiques, 20
rates gravides regurent des doses respectives de 5,5 et
11 mg/kg de poids corporel de Fenoterol par voie sous-
cutanee, du l Seme au 22eme jour de gravidite. Une
cesarienne fut effectuee sur 10 animaux, les foetus
recueillis furent immediatement sacrifies; l'autre
moitie mit bas spontanement et eleva ses petits jusqu'au
21 emc jour de vie. Les poids absolus et relatifs des
coeurs des meres, des foetus et des jeunes animaux
furent determines et analyses sur le plan statistique. Les
coupes histologiques preparees en partie avec une
coloration speciale furent examinees directement et a
l'aide du microscope a lumiere polarisee.
2. L'influx du calcium dans le myocarde fut examine le
21eme jour de gravidite sur 15 animaux divises en 3
groupes de 5. Chaque groupe requt respectivement du
serum physiologique ä 0,85%, 30 mg/kg d'Isoprenalin
ou 11 mg/kg de Fenoterol en voie sous-cutanee. En
tant que traceur, tous les animaux regurent en i.p.
10 Mg/kg de 45CaCl2 (dilue dans l ml de NaCl a 0,85%).
6 heures apres l'application, la radioactivite dans le
ventricule droit et dans le plasma sanguin des foetus et
des meres fut determinee. La concentration de radio-
activite dans le ventricule fut mise en rapport avec celle
du plasma et exprimee en pourcentage.
3. La concentration de Fenoterol et de ses metabolites
dans le myocarde fut determinee chez les meres et les
foetus de 2 groupes de 10 animaux ayant requ par
voie sous-cutanee desdoses respectives de 5,5 et 11 mg/kg
de Fenoterol, du 18eme au 22eme jour de gravidite.
5 animaux de chaque groupe re9urent du Fenoterol
radioactif tous les jours d'application, les autres animaux
n'eurent une application radioactive que le 22eme jour.
Une heure apres la derniere application, on determina
la concentration tissulaire du Fenoterol et de ses
metabolites dans le myocarde maternel et foetal.
Resultats:
1. Les poids du coeur des foeteus avec meres traitees au
Fenoterol ne se differencient pas du groupe de controle
(Tab. I). On observa chez les meres traitees une
augmentation faible du poids du coeur, neanmoins
significative du point de vue statistique. Ni les foetus,
ni les jeunes animaux ne presenterent des Asiens du
myocarde a Fexamen histologique (Tab. II). On observa
chez les meres traitees des modification faibles a
moyennes du myocarde; des zones analogues a celles
des infarctus ne purent etre constatees.
2. Ni le Fenoterol, ni l'Isoprenalin ne provoquerent une
augmentation de l'absorption du Ca dans le ventricule
foetal. L'augmentatipn de l'influx du calcium dans le
myocarde etait nettement plus faible chez les meres
traitees avec le Fenoterol que chez celles traitees avec
PIsoprenalin (Tab. III). Les valeurs exposees en
tableaux montrent en plus que les rats mäies adultes
reagissent sur le plan cardiotoxique plus sensiblement
que les femelles apres un traitement aux catecholamines;
de meme, les non-gravides reagissent plus fortement
que les gravides.
3. Le passage diaplacentaire du Fenoterol et de ses meta-
bolites es t fortement inhibe.Tandis que la concentration
des metabolites s'eleve a une puissance dix fois plus
faible dans le myocarde foetal que dans le myocarde
maternel, la difference de concentration est superieure
a 2 puissances dix avec le Fenoterol lui-meme. Une
cumulation du Fenoterol dans le myocarde foetal apres
applications repetees ne put etre observee. L'absence
de modifications du tissu du myocarde chez les foetus
et les jeunes animaux peut etre attribuee au passage
diaplacentaire extremement faible de la substance
Fenoterol. On ignore quels mecanismes provoquent
cette Inhibition du passage diaplacentaire.
Mots-cles: concentration tissulaire, Fenoterol, foetus, influx du calcium, necrose du myocarde, passage placeritaire,
poids du coeur, rats.
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